Amgen Inc.
AMGN
$369.53
$1.930.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.75% | 10.77% | 13.44% | 16.32% | 19.01% |
| Total Other Revenue | 14.66% | 5.97% | 0.86% | -0.37% | 9.22% |
| Total Revenue | 9.95% | 10.56% | 12.88% | 15.56% | 18.57% |
| Cost of Revenue | 2.42% | 5.35% | 13.84% | 22.84% | 33.98% |
| Gross Profit | 13.38% | 12.94% | 12.46% | 12.57% | 12.67% |
| SG&A Expenses | -0.65% | -0.41% | 2.20% | 11.74% | 24.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -28.76% | 124.97% | 542.86% | -5.81% | 29.66% |
| Total Operating Expenses | 6.22% | 11.69% | 13.36% | 18.57% | 28.65% |
| Operating Income | 19.00% | 8.15% | 11.78% | 9.19% | -0.35% |
| Income Before Tax | 94.75% | 76.19% | 110.61% | 53.05% | -41.32% |
| Income Tax Expenses | 143.74% | 175.95% | 103.80% | 23.20% | -54.39% |
| Earnings from Continuing Operations | 88.53% | 65.60% | 111.47% | 57.67% | -39.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.53% | 65.60% | 111.47% | 57.67% | -39.11% |
| EBIT | 19.00% | 8.15% | 11.78% | 9.19% | -0.35% |
| EBITDA | 9.30% | 4.62% | 11.05% | 13.73% | 11.03% |
| EPS Basic | 88.13% | 65.22% | 110.67% | 56.99% | -39.39% |
| Normalized Basic EPS | 33.07% | 17.79% | 12.72% | -0.85% | -14.80% |
| EPS Diluted | 88.62% | 65.58% | 110.32% | 56.45% | -39.60% |
| Normalized Diluted EPS | 33.16% | 17.84% | 12.60% | -1.11% | -14.86% |
| Average Basic Shares Outstanding | 0.28% | 0.28% | 0.33% | 0.37% | 0.37% |
| Average Diluted Shares Outstanding | 0.28% | 0.32% | 0.51% | 0.70% | 0.37% |
| Dividend Per Share | 5.78% | 5.74% | 5.71% | 5.67% | 5.63% |
| Payout Ratio | -0.44% | -0.36% | -0.50% | -0.33% | 0.74% |